Publikationen in Zusammenarbeit mit Forschern von Chinese University of Hong Kong (1)

2021

  1. Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design

    Future Oncology, Vol. 17, Núm. 12, pp. 1459-1472